MedTrace Logo

Foam Roller Versus Self-Performed Neurodynamic Sliding in People With Hamstring Tightness and Low Back Pain History

NCT07627581 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-06-08

No results posted yet for this study

Summary

This randomized crossover pilot clinical trial evaluated the effects of two self-administered physiotherapy techniques in people with hamstring tightness and a history of non-specific low back pain.

Participants were randomly assigned to one of two treatment sequences. One sequence performed self-myofascial release using a foam roller first, followed by a one-month washout period, and then performed a self-administered neurodynamic sliding technique. The other sequence performed the neurodynamic sliding technique first, followed by a one-month washout period, and then performed the foam roller intervention.

The main objective of the study was to compare the effects of both interventions on hamstring flexibility. Secondary outcomes included active knee extension range of motion, dynamic balance, pressure pain threshold, hamstring and gluteus maximus strength, and low back pain intensity.

Conditions

  • Low Back Pain
  • Hamstring Tightness

Interventions

OTHER

Self-Myofascial Release Using a Foam Roller

Participants will perform bilateral self-myofascial release of the hamstring muscles using a foam roller. The technique will be performed for 2 minutes per leg over three consecutive days.

OTHER

Self-Administered Neurodynamic Sliding Technique

Participants will perform a seated self-administered neurodynamic sliding technique over three consecutive days. The intervention will consist of 3 sets of 20 repetitions, with 20 seconds of rest between sets.

Sponsors & Collaborators

  • Universidad Pontificia de Salamanca

    lead OTHER

Principal Investigators

  • Sara Perpiña Martínez, PT, PhD · Pontifical University of Salamanca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07627581 on ClinicalTrials.gov